Zupitor 10mg Tablet contains Rosuvastatin, a potent HMG-CoA reductase inhibitor used primarily to manage hypercholesterolemia and reduce the risk of cardiovascular disease. Rosuvastatin works by inhibiting the enzyme responsible for cholesterol synthesis in the liver, leading to decreased low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels, while modestly increasing high-density lipoprotein cholesterol (HDL-C). This medication is indicated for patients with primary hyperlipidemia, mixed dyslipidemia, and familial hypercholesterolemia, as well as for the prevention of atherosclerotic cardiovascular disease in patients with multiple risk factors. Zupitor 10mg is typically administered once daily, with or without food, and dosage adjustments are based on therapeutic response and patient tolerance. It is important to monitor liver function tests and lipid profiles periodically during treatment. Patients should be advised to maintain a cholesterol-lowering diet and lifestyle modifications to optimize therapeutic outcomes. Common adverse effects may include headache, myalgia, abdominal pain, and nausea. Rare but serious side effects include myopathy and rhabdomyolysis. Zupitor 10mg should be used cautiously in patients with hepatic impairment or a history of muscle disorders, and it is contraindicated during pregnancy and lactation. Regular follow-up with healthcare providers is essential to ensure safety and efficacy.